The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Carfilzomib or bortezomib with lenalidomide, and dexamethasone (VRd) for initial therapy of newly diagnosed multiple myeloma (NDMM): Long-term follow-up of the ECOG-ACRIN ENDURANCE phase 3 trial.
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); K36 (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Allogene Therapeutics (Inst); Bristol-Myers Squibb/Celgene (Inst); CARsgen Therapeutics (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); MedImmune (Inst); Novartis (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Beigene; Janssen; Pfizer
 
Edward Faber
No Relationships to Disclose
 
Adam Cohen
Consulting or Advisory Role - Abbvie; Arcellx; Bristol Meyers Squibb; GlaxoSmithKline; Ichnos Sciences; ITeos Therapeutics; Janssen Oncology; Novartis; Pfizer; Roche/Genentech; Takeda
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patents related to CAR T cells and biomarkers of Cytokine Release Syndrome
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Ichnos Sciences; Janssen Oncology; Janssen Oncology
 
Natalie Callander
No Relationships to Disclose
 
Avina Singh
No Relationships to Disclose
 
Terri Parker
No Relationships to Disclose
 
Alex Menter
No Relationships to Disclose
 
Xuezhong Yang
No Relationships to Disclose
 
Benjamin Parsons
No Relationships to Disclose
 
Pankaj Kumar
No Relationships to Disclose
 
Prashant Kapoor
Honoraria - Abbvie (Inst); Abbvie (Inst); AstraZeneca; BeiGene; MustangBio; Pharmacyclics; Sanofi (Inst)
Consulting or Advisory Role - Sanofi (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); GlaxoSmithKline (Inst); Ichnos Sciences (Inst); Karyopharm Therapeutics (Inst); Regeneron (Inst); Sanofi (Inst); Sorrento Therapeutics (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen; Sanofi
 
Rosenberg Aaron
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene
Research Funding - Biomea Fusion; Kangpu Biopharmaceuticals; Pfizer
 
Jeffrey Zonder
Employment - Bristol-Myers Squibb/Celgene (I)
Consulting or Advisory Role - Sanofi/Regeneron; Takeda
Research Funding - BMS (Inst); Janssen Oncology
 
Kenneth Anderson
Leadership - C4 Therapeutics; Dynamic Cell Therapies; predicta biosciences; starton therapeutics; window therapeutics
Stock and Other Ownership Interests - C4 Therapeutics; NextRNA; OncoPep; predicta biosciences; Raqia; STARTON Therapeutics; Window Therapeutics
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Janssen Oncology; Pfizer
Patents, Royalties, Other Intellectual Property - C4 Therapeutics; Oncopep
 
Sagar Lonial
Stock and Other Ownership Interests - TG Therapeutics
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Merck; Novartis; Pfizer; Regeneron; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb; Celgene; Janssen Oncology; Novartis; Takeda
Other Relationship - TG Therapeutics
 
Paul Richardson
No Relationships to Disclose
 
Robert Orlowski
Stock and Other Ownership Interests - Asylia Therapeutics, Inc.
Honoraria - AbbVie, Adaptive Biotech, Asylia Therapeutics, Inc., BioTheryX, Bristol-Myers Squibb Pharmaceuticals, DEM BioPharma, Inc., Karyopharm Therapeutics, Lytica Therapeutics, Meridian Therapeutics, Monte Rosa Therapeutics, Myeloma 360, Nanjing IASO Biotherapeut (Inst)
Consulting or Advisory Role - AbbVie, Adaptive Biotech, Asylia Therapeutics, Inc., BioTheryX, Bristol-Myers Squibb Pharmaceuticals, DEM BioPharma, Inc., Karyopharm Therapeutics, Lytica Therapeutics, Meridian Therapeutics, Monte Rosa Therapeutics, Myeloma 360, Nanjing IASO Biotherapeut (Inst)
Research Funding - Clinical Research Funding Bristol-Myers Squibb Pharmaceuticals, CARsgen Therapeutics, Exelixis, Heidelberg Pharma, Janssen, Sanofi, Takeda Pharmaceuticals Laboratory Research Funding Asylia Therapeutics, Inc., Heidelberg Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Asylia Therapeutics, Inc. (Inst)
 
Lynne Wagner
Consulting or Advisory Role - Celgene
Travel, Accommodations, Expenses - Celgene
 
S. Vincent Rajkumar
No Relationships to Disclose
 
Susanna Jacobus
No Relationships to Disclose